Skip to content
Search

Latest Stories

Lloyds Pharmacy’s decision to close all Sainsbury’s branches worries pharmacy bodies

The pharmacy bodies have expressed a deep concern over Lloyds Pharmacy ’s announcement on plans to close all pharmacy branches located in Sainsbury’s before the end of 2023.

Pharmaceutical Services Negotiating Committee (PSNC) Chief Executive Janet Morrison said: “This significant shrinkage by the second largest pharmacy chain is an extremely worrying development and one of the clearest signals yet of just how much all community pharmacies are struggling to make ends meet. We know that many are at breaking point.”


She added: “We understand that LloydsPharmacy will be in touch directly with affected staff and patients at this difficult time. As these pharmacies close, other pharmacies locally will be braced for even more pressures as they try to cope with increased demand.”

“The announcement by LloydsPharmacy will be of concern to staff, patients, the public and the community pharmacy sector alike,” Malcolm Harrison, Chief Executive of the Company Chemists’ Association (CCA).

Pharmacists, and other employees, working at pharmacies owned and operated by LloydsPharmacy in Sainsbury’s have been told that the group of more than 200 pharmacies will be closed this year as LloydsPharmacy will be ending their relationship with the supermarket chain.

The Pharmacist Defence Association (PDA) Union will provide PDA members with information, support and representation in order that they are aware of and can exercise their rights at work in relation to this situation.

As the recognised trade union at LloydsPharmacy, PDA officials were given confidential notice before the announcement and are able to continue to represent the interests of pharmacists in discussions with the company.

Mark Pitt, Assistant General Secretary of the PDA Union said, “We have seen many disposals of Lloyds Pharmacy branches over recent months and we know more may occur, however for every disposal there has been a buyer, therefore patients and communities have seen no reduction in availability, the pharmacy network has not lost capacity and there were no job losses.

This situation is different and means significant reductions in access to a pharmacy for patients and we expect those who represent communities to be concerned about the loss of a key part of their local NHS service.

Forward-thinking governments around the UK are seeking to make greater use of pharmacies as the most accessible contact point in the NHS, to reduce pressure on other parts of the healthcare system, so there should be greater community pharmacy capacity, not less.”

According to PSNC, the sharp decline in community pharmacy funding combined with workforce and other pressures is making it ‘increasingly difficult to sustain services and impossible to do more’.

The committee stressed that pharmacies urgently need investment from Government to ensure they can continue to offer the services that so many patients rely on and this is why the sector has this week announced its #saveourpharmacies campaign.

Morrison said: “Without further investment, we believe more permanent closures are likely and this will only increase the risk of serious difficulty for patients’ in accessing services and medicines: Government must not allow this to happen. I am calling on Ministers to meet me for meaningful talks to avoid such a catastrophe.”

“Policymakers cannot escape the fact that the funding model for community pharmacy is broken,” said Harrison.

“As we and other pharmacy bodies have warned recently, we are at an indisputable fork in the road for the NHS. At a time when General Practice and the NHS is struggling with ever-increasing demand, allowing the community pharmacy network to wither and decline will make no sense to patients and the public. Again, we call on the Government to act.

If new and recurrent funding is not forthcoming, it is very likely that the rate of permanent closures will increase with far-reaching impacts on the capacity and resilience of the pharmacy network.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less